Speckle-type POZ protein Antibodies

AND SPOP ELISA kits, Speckle-type POZ protein Proteins

Many biological assays use antibodies to detect Speckle-type POZ protein, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with Speckle-type POZ protein in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop Speckle-type POZ protein antibodies...

We validate the specificity of these antibodies to Speckle-type POZ protein by testing them on tissues known to express SPOP positively and negatively. Browse below to find the SPOP antibody that suites your experiment. We have 5 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: CBLIF Next: SRPX

SPOP Infographic by Boster Bio

All SPOP Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

Anti-SPOP Antibody

4 Q&As

Human, Mouse, Rat

IHC, WB

$399
Cat # A02032
100μl

Human SPOP Recombinant Protein

SDS-PAGE

$265
Cat # PROTO43791
Starting from 10ug

Anti-SPOP Rabbit Monoclonal Antibody

Human

$370
Cat # M02032
100 μl/vial

SPOP (NM_001007226) Human Over-expression Lysate

Human

$628
Cat # LS008405
100 µg

Anti-SPOP Antibody Picoband®

Human

$370
Cat # A02032-2
100 μg/vial

SPOP Overview

Facts about Speckle-type POZ protein.

SPOP 3D structure. Source: alphafold

Speckle-type POZ protein (SPOP)

Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates the ubiquitination of target proteins, leading most often to their proteasomal degradation. In complex with CUL3, involved in ubiquitination and proteasomal degradation of BRMS1, DAXX, PDX1/IPF1, GLI2 and GLI3.

In complex with CUL3, involved in ubiquitination of H2AFY and BMI1; this does not lead to their proteasomal degradation. Inhibits transcriptional activation of PDX1/IPF1 targets, such as insulin, by promoting PDX1/IPF1 degradation.